On the other hand, the 19-protein biomarker panel generated in a recent large-scale study of an Asian cohort also did not include APOE but was nevertheless able to distinguish patients with AD irrespective of their APOE genotype [37]. This evidence concerns the gene APOE and Alzheimer disease.